Gufic Biosciences Ltd (GUFICBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Gufic Biosciences Ltd reported sales of ₹261 Cr, operating profit of ₹47 Cr (OPM 18%) and net profit of ₹22 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
GUFICBIO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 204 208 205 224 237 231 252 261 Expenses 166 174 179 190 199 198 205 214 Operating Profit 39 34 26 33 38 33 47 47 OPM 19% 16% 13% 15% 16% 14% 19% 18% Other Income 0 2 0 1 2 1 -1 0 Interest 5 5 8 9 10 8 9 9 Depreciation 4 5 8 8 8 8 8 8 Profit before tax 29 26 11 17 23 18 29 30 Tax 26% 26% 27% 24% 26% 30% 24% 26% Net Profit 22 19 8 13 17 12 22 22 EPS in Rs 2.17 1.93 0.77 1.3 1.68 1.24 2.18 2.22
GUFICBIO profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 TTM Sales 807 820 944 981 Expenses 657 684 793 816 Operating Profit 150 136 151 165 OPM 19% 17% 16% 17% Other Income 0 4 3 2 Interest 17 25 37 37 Depreciation 17 21 31 31 Profit before tax 116 94 87 99 Tax 26% 26% 26% - Net Profit 86 70 64 73 EPS in Rs 8.59 6.95 6.4 7.32 Dividend Payout 1% 1% 2% -
GUFICBIO balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 10 10 10 10 Reserves 523 591 621 655 Borrowings 333 336 369 405 Other Liabilities 227 232 271 273 Total Liabilities 1,093 1,169 1,271 1,342 Fixed Assets 159 506 495 491 CWIP 307 22 24 22 Investments 2 2 2 2 Other Assets 625 640 750 827 Total Assets 1,093 1,169 1,271 1,342
GUFICBIO cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -7 123 45 Cash from Investing Activity -102 -71 -31 Cash from Financing Activity 82 -37 32 Net Cash Flow -27 15 46 Free Cash Flow -116 52 14 CFO/OP 13% 107% 38%
GUFICBIO ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 149 140 115 Inventory Days 188 211 281 Days Payable 156 155 172 Cash Conversion Cycle 181 197 224 Working Capital Days 97 93 80 ROCE - 13% 12%